Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-24 · accession 0001127602-25-006578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-25 | 2025-02-24 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $1.50 | +73.3K | 534.9K | +16% | +$110.0K |
| D | 2025-02-25 | 2025-02-24 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $1.87 | +73.3K | 73.3K | New | +$137.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | P | A | 73,333 | $1.50 | 534,885 | D | — | — | (F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were isused under the Issuer's 2021 Equity Incentive Plan on February 24, 2024. |
| 2 | Derivative | Warrants | 2025-02-24 | P | A | 73,333 | $1.87 | 73,333 | D | $1.87 · 2025-08-24 to 2030-08-24 | 73,333 Common Stock | (F2) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date. |